• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计开发和优化多功能阿霉素负载吲哚菁绿前体囊泡衍生的非离子囊泡用于肿瘤管理。

Design development and optimisation of multifunctional Doxorubicin-loaded Indocynanine Green proniosomal gel derived niosomes for tumour management.

机构信息

Department of Pharmaceutics, SRM College of Pharmacy, Kattankulathur, 603 203, India.

Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, 603 203, India.

出版信息

Sci Rep. 2023 Jan 30;13(1):1697. doi: 10.1038/s41598-023-28891-8.

DOI:10.1038/s41598-023-28891-8
PMID:36717736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9886914/
Abstract

This study presents the design, development, and optimization of multifunctional Doxorubicin (Dox)-loaded Indocyanine Green (ICG) proniosomal gel-derived niosomes, using Design of Experiments (2 factorial model). Herein, the multifunctional proniosomal gel was prepared using the coacervation phase separation technique, which on hydration forms niosomes. The effect of formulation variables on various responses including Zeta potential, Vesicle size, entrapment efficiency of Dox, entrapment efficiency of ICG, Invitro drug release at 72nd hour, and NIR hyperthermia temperature were studied using statistical models. On the basis of the high desirability factor, optimized formulation variables were identified and validated with the experimental results. Further, the chemical nature, vesicle morphology, surface charge, and vesicle size of optimized proniosomal gel-derived niosomes were evaluated. In addition, the effect of free ICG and bound ICG on NIR hyperthermia efficiency has been investigated to demonstrate the heating rate and stability of ICG in the aqueous environment and increased temperature conditions. The drug release and kinetic studies revealed a controlled biphasic release profile with complex mechanisms of drug transport for optimized proniosomal gel-derived niosomes. The potential cytotoxic effect of the optimised formulation was also demonstrated invitro using HeLa cell lines.

摘要

本研究采用实验设计(2 因子模型),介绍了多柔比星(DOX)负载吲哚菁绿(ICG)前体囊泡衍生囊泡的设计、开发和优化。在此,多功能前体囊泡是通过凝聚相分离技术制备的,该技术在水合时形成囊泡。使用统计模型研究了制剂变量对各种响应的影响,包括 Zeta 电位、囊泡大小、DOX 的包封效率、ICG 的包封效率、72 小时时的体外药物释放和 NIR 热疗温度。基于高理想因子,确定了优化的制剂变量,并通过实验结果进行了验证。此外,还评估了优化的前体囊泡衍生囊泡的化学性质、囊泡形态、表面电荷和囊泡大小。此外,还研究了游离 ICG 和结合 ICG 对 NIR 热疗效率的影响,以证明 ICG 在水相环境和升高温度条件下的加热速率和稳定性。药物释放和动力学研究表明,优化的前体囊泡衍生囊泡具有复杂的药物传输机制的控制双相释放曲线。还使用 HeLa 细胞系在体外证明了优化配方的潜在细胞毒性作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/ff6246d4e3d3/41598_2023_28891_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/e38a3d712202/41598_2023_28891_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/6b12c6b7b5d6/41598_2023_28891_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/607a29ef8183/41598_2023_28891_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/347e5b7b31fc/41598_2023_28891_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/00f96a6b4f2a/41598_2023_28891_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/e247d94ff6a5/41598_2023_28891_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/174ff342fd66/41598_2023_28891_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/72c2d1f8e4e9/41598_2023_28891_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/340d31d0c7ae/41598_2023_28891_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/c2dd9e04ab58/41598_2023_28891_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/ffaa28ef924a/41598_2023_28891_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/d42f6aae3360/41598_2023_28891_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/c7fc69d576f9/41598_2023_28891_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/ff6246d4e3d3/41598_2023_28891_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/e38a3d712202/41598_2023_28891_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/6b12c6b7b5d6/41598_2023_28891_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/607a29ef8183/41598_2023_28891_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/347e5b7b31fc/41598_2023_28891_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/00f96a6b4f2a/41598_2023_28891_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/e247d94ff6a5/41598_2023_28891_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/174ff342fd66/41598_2023_28891_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/72c2d1f8e4e9/41598_2023_28891_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/340d31d0c7ae/41598_2023_28891_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/c2dd9e04ab58/41598_2023_28891_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/ffaa28ef924a/41598_2023_28891_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/d42f6aae3360/41598_2023_28891_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/c7fc69d576f9/41598_2023_28891_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/620f/9886914/ff6246d4e3d3/41598_2023_28891_Fig14_HTML.jpg

相似文献

1
Design development and optimisation of multifunctional Doxorubicin-loaded Indocynanine Green proniosomal gel derived niosomes for tumour management.设计开发和优化多功能阿霉素负载吲哚菁绿前体囊泡衍生的非离子囊泡用于肿瘤管理。
Sci Rep. 2023 Jan 30;13(1):1697. doi: 10.1038/s41598-023-28891-8.
2
Formulation and evaluation of proniosomes containing lornoxicam.载有氯诺昔康的前体药物的配方与评估。
Drug Deliv Transl Res. 2016 Oct;6(5):511-8. doi: 10.1007/s13346-016-0296-9.
3
Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats.前体脂质体凝胶经皮传递洛索洛芬:利用析因设计和大鼠体内评价进行优化。
Daru. 2019 Jun;27(1):59-70. doi: 10.1007/s40199-019-00242-x. Epub 2019 Jan 30.
4
Systematically optimized coenzyme q10-loaded novel proniosomal formulation for treatment of photo-induced aging in mice: characterization, biocompatibility studies, biochemical estimations and anti-aging evaluation.用于治疗小鼠光致衰老的系统优化的载辅酶Q10新型前体脂质体制剂:表征、生物相容性研究、生化评估及抗老化评价
J Drug Target. 2016;24(3):257-71. doi: 10.3109/1061186X.2015.1077845. Epub 2015 Aug 24.
5
Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.用于经鼻途径脑递送的5-羟色胺受体激动剂盐酸丁螺环酮的脂质体原位鼻腔凝胶的制剂与评价
Pharm Nanotechnol. 2018;6(1):69-78. doi: 10.2174/2211738506666180130105919.
6
Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes.利用绿色制剂技术和细胞系研究评估尼莫司汀的双重抗癌药物疗法的疗效。
Int J Pharm. 2019 Dec 15;572:118764. doi: 10.1016/j.ijpharm.2019.118764. Epub 2019 Oct 16.
7
Development and optimization of boswellic acid-loaded proniosomal gel.载乳香酸前体脂质体凝胶的研制与优化
Drug Deliv. 2016 Oct;23(8):3072-3081. doi: 10.3109/10717544.2016.1149744. Epub 2016 Mar 8.
8
Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.载拉西地平的尼奥斯omal 凝胶透皮给药的制剂及优化:体外特性及体内活性。
Biomed Pharmacother. 2017 Sep;93:255-266. doi: 10.1016/j.biopha.2017.06.043. Epub 2017 Jul 18.
9
Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability.采用Box-Behnken设计优化载甲氨蝶呤脂质体:对溶剂效应和制剂变异性的理解
Drug Dev Ind Pharm. 2017 Sep;43(9):1450-1459. doi: 10.1080/03639045.2017.1318907. Epub 2017 Apr 27.
10
Preparation and evaluation of transdermal naproxen niosomes: formulation optimization to preclinical anti-inflammatory assessment on murine model.萘普生经皮传递脂质体的制备与评价:用于小鼠模型临床前抗炎评估的配方优化
J Liposome Res. 2020 Dec;30(4):377-387. doi: 10.1080/08982104.2019.1652646. Epub 2019 Aug 15.

引用本文的文献

1
Tailored transethosomal systems for tadalafil transdermal delivery: Impact of Phosal and edge activators on skin permeation and cellular uptake.用于他达拉非经皮递送的定制转质体系统:磷脂和边缘活化剂对皮肤渗透和细胞摄取的影响。
Int J Pharm X. 2025 Aug 16;10:100376. doi: 10.1016/j.ijpx.2025.100376. eCollection 2025 Dec.
2
Bioadhesive hybrid system of niosomes and pH sensitive gel for itraconazole ocular delivery: Dual approach for efficient treatment of fungal infections.用于伊曲康唑眼部给药的脂质体与pH敏感凝胶的生物粘附混合系统:高效治疗真菌感染的双重方法
Saudi Pharm J. 2024 Dec;32(12):102208. doi: 10.1016/j.jsps.2024.102208. Epub 2024 Nov 22.
3

本文引用的文献

1
Platelet-armored nanoplatform to harmonize janus-faced IFN-γ against tumor recurrence and metastasis.血小板装甲纳米平台协调两面神干扰素-γ 以对抗肿瘤复发和转移。
J Control Release. 2021 Oct 10;338:33-45. doi: 10.1016/j.jconrel.2021.08.020. Epub 2021 Aug 13.
2
Engineering of a dual-modal phototherapeutic nanoplatform for single NIR laser-triggered tumor therapy.工程化双模态光疗纳米平台用于单近红外激光触发的肿瘤治疗。
J Colloid Interface Sci. 2021 Jul 15;594:493-501. doi: 10.1016/j.jcis.2021.03.050. Epub 2021 Mar 17.
3
Rational design of a minimalist nanoplatform to maximize immunotherapeutic efficacy: Four birds with one stone.
Efficient Delivery of Gold Nanoparticles and miRNA-33a Via Cationic PEGylated Niosomal Formulation to MCF-7 Breast Cancer Cells.
阳离子 PEG 化介孔脂质体纳米囊载金纳米颗粒及 miRNA-33a 递送至 MCF-7 乳腺癌细胞的效率研究。
AAPS PharmSciTech. 2024 Sep 12;25(7):213. doi: 10.1208/s12249-024-02906-7.
4
Preparation and characterization of artemether-loaded niosomes in Leishmania major-induced cutaneous leishmaniasis.载青蒿琥酯的尼莫司汀脂质体的制备及表征在利什曼原虫诱导的皮肤利什曼病中的应用。
Sci Rep. 2024 May 2;14(1):10073. doi: 10.1038/s41598-024-60883-0.
5
Development and Optimization of Proniosomal Formulation of Irbesartan Using a Box-Behnken Design to Enhance Oral Bioavailability: Physicochemical Characterization and Assessment.使用Box-Behnken设计开发和优化厄贝沙坦前体脂质体制剂以提高口服生物利用度:理化特性及评估
ACS Omega. 2024 Mar 25;9(14):16346-16357. doi: 10.1021/acsomega.3c10506. eCollection 2024 Apr 9.
从最小化纳米平台出发进行合理化设计,以最大化免疫治疗效果:一石四鸟。
J Control Release. 2020 Dec 10;328:617-630. doi: 10.1016/j.jconrel.2020.09.035. Epub 2020 Sep 22.
4
Indocyanine Green and Curcumin Co-Loaded Nano-Fireball-Like Albumin Nanoparticles Based on Near-Infrared-Induced Hyperthermia for Tumor Ablation.基于近红外光诱导热疗的吲哚菁绿和姜黄素共载纳米火球样白蛋白纳米粒子用于肿瘤消融。
Int J Nanomedicine. 2020 Sep 1;15:6469-6484. doi: 10.2147/IJN.S262690. eCollection 2020.
5
Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.多柔比星和姜黄素共递送的多肽纳米载体用于协同淋巴瘤治疗。
Sci Rep. 2020 May 12;10(1):7832. doi: 10.1038/s41598-020-64828-1.
6
Evaluations of Quality by Design (QbD) Elements Impact for Developing Niosomes as a Promising Topical Drug Delivery Platform.质量源于设计(QbD)要素对开发作为一种有前景的局部给药平台的纳米囊泡的影响评估
Pharmaceutics. 2020 Mar 9;12(3):246. doi: 10.3390/pharmaceutics12030246.
7
A comparison of models for the analysis of the kinetics of drug release from PLGA-based nanoparticles.基于聚乳酸-羟基乙酸共聚物(PLGA)的纳米颗粒药物释放动力学分析模型的比较
Heliyon. 2020 Feb 28;6(2):e03451. doi: 10.1016/j.heliyon.2020.e03451. eCollection 2020 Feb.
8
The Why, Where, Who, How, and What of the vesicular delivery systems.囊泡递药系统的来龙去脉。
Adv Colloid Interface Sci. 2019 Sep;271:101985. doi: 10.1016/j.cis.2019.07.006. Epub 2019 Jul 9.
9
Mathematical Modeling of Release Kinetics from Supramolecular Drug Delivery Systems.超分子药物递送系统释放动力学的数学建模
Pharmaceutics. 2019 Mar 21;11(3):140. doi: 10.3390/pharmaceutics11030140.
10
Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats.前体脂质体凝胶经皮传递洛索洛芬:利用析因设计和大鼠体内评价进行优化。
Daru. 2019 Jun;27(1):59-70. doi: 10.1007/s40199-019-00242-x. Epub 2019 Jan 30.